Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taselisib + Enzalutamide in AR+ TNBC
NCT02457910Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jun 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of taselisib / pictilisib in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Jun 2015; status: terminated.
02
Drugs
taselisib / pictilisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02457910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457910.